Halxim CV Tablets: Broad-Spectrum Treatment for Respiratory Infections

Halxim CV Tablets contain a synergistic blend of Cefixime (200mg) and Clavulanic Acid (125mg), offering potent antibacterial activity against a wide spectrum of respiratory infections.

Key Features:

* Broad-spectrum coverage: This combination effectively targets gram-negative bacteria, including Haemophilus influenzae, Moraxella catarrhalis, and some strains of Proteus mirabilis - commonly associated with respiratory illnesses like bronchitis and sinusitis.
* Dual action synergy: Cefixime, a second-generation cephalosporin, inhibits bacterial cell wall synthesis. Clavulanic acid acts as a beta-lactamase inhibitor, ensuring the antibacterial activity of Cefixime persists against bacteria that produce these enzymes.
* Oral administration: This convenient tablet form is easily administered for effective and targeted treatment.

Note: Consult with a healthcare professional before starting any medication to ensure suitability and dosage based on individual needs.

This description provides information about the drug, its mechanism of action, key features, and dosage considerations, highlighting the product's suitability for online pharmacy customers seeking reliable and trustworthy medication options.